UP!

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q3 2020 2020-11-03 Future report Set alerts
Q2 2020 2020-08-04 0.00 0.00
Q4 2019 2020-06-24 0.00 -0.26
Q3 2019 2020-06-24 0.00 -0.19
Q2 2019 2020-06-24 0.00 -0.22
Q1 2020 2020-05-12 0.00 -0.28
Q1 2019 2020-05-12 0.00 -0.30
Q4 2018 2019-03-26 -0.18 -0.18
Q3 2018 2018-11-01 -0.22 -0.22
Q2 2018 2018-08-02 -0.26 -0.26

Ratings

2016-06-13 Reiterated Rating FBR & Co. Buy
2016-06-13 Reiterated Rating FBR & Co Buy
2016-06-03 Reiterated Rating Robert W. Baird Outperform $7.00
2016-05-10 Reiterated Rating FBR & Co. Buy
2016-05-05 Initiated Coverage Cowen and Company Outperform
2016-04-27 Reiterated Rating Cowen and Company Outperform
2016-03-01 Initiated Coverage SunTrust Buy $3.00
2016-03-01 Initiated Coverage SunTrust Banks Inc. Buy $3.00
2016-02-29 Reiterated Rating Roth Capital Buy $5.00
2015-11-09 Lower Price Target Roth Capital Buy $6.00 to $5.00
2015-10-19 Reiterated Rating Robert W. Baird Buy $7.00
2015-10-19 Reiterated Rating Roth Capital Buy $5.00
2015-08-11 Initiated Coverage FBR & Co. Outperform $6.00
2015-08-10 Lower Price Target Roth Capital Buy $6.00 to $5.00
2015-07-25 Reiterated Rating Roth Capital Buy
2015-07-06 Reiterated Rating Oppenheimer Outperform
2015-07-06 Reiterated Rating Oppenheimer Holdings Inc. Outperform
2015-06-02 Set Price Target Roth Capital Buy $6.00
2015-06-01 Boost Price Target Robert W. Baird Outperform $5.00 to $7.00
2015-05-16 Reiterated Rating Stifel Nicolaus Hold
2015-04-20 Set Price Target Robert W. Baird Buy $5.00
2015-01-22 Boost Price Target Oppenheimer Outperform $3.00 to $5.00
2015-01-21 Lower Price Target Roth Capital Buy $10.00 to $6.00
2014-10-16 Reiterated Rating Roth Capital Positive
2014-05-09 Lower Price Target Oppenheimer Outperform $4.50 to $3.00
2014-03-24 Lower Price Target Roth Capital $10.00 to $9.00
2013-12-05 Initiated Coverage Wedbush Outperform $6.00
2013-11-21 Lower Price Target Mackie Speculative Buy C$1.80 to C$1.20
2013-11-07 Downgrade BMO Capital Markets Outperform to Market Perform $8.00 to $3.00
2013-10-01 Initiated Coverage Robert W. Baird Outperform $7.00
2013-09-30 Initiated Coverage Chardan Capital Buy $6.00
2012-01-31 Reiterated Summer Street Research Buy $5 to $7
2011-10-06 Initiated Summer Street Research Buy $5
2011-09-22 Initiated MLV Capital Buy $8.50
2011-03-21 Reiterated Brean Murray Buy $4 to $5
2010-02-26 Reiterated Roth Capital Buy $5 to $4.50
2010-01-07 Initiated Roth Capital Buy $5
2009-11-24 Initiated ThinkEquity Buy
2009-03-25 Initiated Merriman Curhan Ford Buy
2016-06-13 Reiterated Rating FBR & Co. Buy
2016-06-13 Reiterated Rating FBR & Co Buy
2016-06-03 Reiterated Rating Robert W. Baird Outperform $7.00
2016-05-10 Reiterated Rating FBR & Co. Buy
2016-05-05 Initiated Coverage Cowen and Company Outperform

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
Fattaey Ali Ph.D. President & COO 0.37%  (322140) CRIS /
Rubin Marc 0.28%  (236596) CRIS / GALT / TTNP /
GREENACRE MARTYN D 0.26%  (222945) CRIS / NBS /
KAITIN KENNETH I 0.25%  (214607) CRIS /
Dentzer James E Chief Financial Officer 0.25%  (212011) CRIS / DRNA /
PASSERI DANIEL R CEO and Director 0.25%  (211798) CRIS /
Martell Robert 0.22%  (185000) CRIS /
Kunkel Lori Anne 0.22%  (185000) CRIS / LOXO /
Tuck David Chief Medical Officer 0.20%  (169424) CRIS /
TOBIN JAMES R 0.17%  (144921) CRIS / GMED / OXFD /
GRAY MICHAEL COO and CFO 0.12%  (107304) CRIS /
MCNAB JAMES R 0.06%  (50000) CRIS / TTNP /
Pienta Kenneth 0.03%  (30000) CRIS /
NOEL MARK Vice-President 0.03%  (27540) CRIS /
BAYH SUSAN B 0.03%  (25000) CRIS / DNDN / DYAX / EMMS / MRNA /

Comments